Dr Reddy’s Q1 net decreases 76% at Rs 154 crore
Dr Reddy’s Laboratories Ltd, which is India’s second-largest drugmaker has posted 76% decline in its Q1 on account of fierce competition in its largest market,...
Tag : Dr Reddy’s
Dr Reddy’s has signed US licensing agreement with XenoPort
Dr Reddy’s Laboratories and XenoPort have entered into a US licensing agreement. Dr Reddy’s Laboratories will be paying an upfront fee of USD 50 million...
Dr Reddy’s, TR-Pharma collaborates for 3 biosimilars
Dr Reddy’s Laboratories Ltd and Turkey based TR-Pharma has entered into a strategic collaboration agreement involving three biosimilar products. The company has said in a...
Dr Reddy’s board has approved share buyback for Rs 1,569.4 crore
Dr Reddy’s is going to buyback around 44.85 lakh shares that accounts for about 2.6 percent of the existing paid up capital of the company,...
Dr Reddy’s has received USFDA approval to market Sernivo spray
On Monday, the drug major Dr Reddy’s Laboratories (DRL) said that its US subsidiary Promius Pharma has got approval from the USDFA for marketing Sernivo...
USFDA has given a warning letter to Dr Reddy’s for three drug plants
The US Food and Drug Administration has given a warning letter to Dr Reddy’s Laboratories Ltd over inadequate quality control procedures at three manufacturing plants...